Skip to main content
Epistemic AI

Strategic intelligence for biopharma

Finished analysis.
Verified by scientists.

Competitive landscapes, target product profiles, and conference intelligence for biopharma decisions.

Our AI agents and scientists work over the same connected evidence, with experts shaping the analysis throughout.

Talk to our team Explore the analysis

  • 4

    of the largest pharmaceutical companies are Epistemic clients.

  • 10B+ nodes 25B+ edges

    in the Epistemic Knowledge Graph. See the platform

  • Nature Reviews Drug Discovery

    published our analysis of a decade of clinical trial terminations. Read the paper

Solutions

Three analyses for portfolio, product, and competitive decisions.

More evidence, sooner. More options before you commit. Start with the question your team needs to answer.

Where should we focus?

Competitive landscapes

Compare assets, indications, and competitors. Understand the evidence behind the opportunity.

  • Asset landscapes
  • Gap analysis
  • Portfolio intelligence
Explore

How will we differentiate?

Target product profiles

Define your product against clinical and commercial benchmarks, with the reasoning made clear.

  • Clinical benchmarks
  • Target positioning
  • Evidence review
Explore

What changes our strategy?

Conference intelligence

Know what changed and what it means. Put new evidence in the context of your competitive landscape.

  • Conference readiness
  • Evidence updates
  • Strategic briefings
Explore

See a sample analysis

We can walk your team through a redacted competitive landscape, target product profile, conference intelligence, and real-world evidence analysis.

Delivered as dashboards, reports, executive decks, or structured data.

Request a walkthrough

In practice

One oncology landscape grew into five workstreams.

Work starts with one question and expands as the connected evidence builds up.

Competitive intelligence

1 → 5 workstreams from one indication

An oncology landscape grew into TPPs, conference intelligence, target identification, and portfolio trend analysis.

Target product profiles

Head-to-head TPP win

Our target product profile won a head-to-head evaluation at a top-20 pharma company.

Conference intelligence

30+ conferences per year

Readiness and evidence updates for a top-20 pharma company.

Results from individual programs, described without client names. Timing depends on scope, evidence availability, and scientific review.

Our approach

AI agents, a knowledge graph, and scientists in one system.

One system, from question to conclusion.

Scientists shape the scope, evidence gathering, interpretation, and conclusions. Our agents and proprietary knowledge graph make that work possible at scale.

ResearchSpecialized AI agents

Investigate your question across publications, trials, regulatory documents, and other sources.

Deliberate evidence gathering
ContextOur knowledge graph

Connect drugs, targets, diseases, trials, companies, and source records across more than 10 billion nodes.

Connected, traceable evidence
JudgmentOur scientists

Shape the research, challenge the reasoning, and guide the interpretation and conclusions throughout.

Scientific expertise throughout Meet our team

Start with your decision. Agree the scope, format, and update cadence.

See the platform Explore plans

Working with Epistemic

Questions teams ask before they start.

A clear scope. Evidence you can inspect. Analysis built around your decision.

Explore ways to begin
What does my team receive?

A competitive landscape, target product profile, conference briefing, or related strategic analysis. We agree the question, evidence scope, and output format with you, then deliver through live dashboards, reports, executive decks, or structured data.

How are scientists involved?

Our life-science experts shape the scope, evidence gathering, interpretation, and conclusions throughout the work. They challenge the reasoning and review the analysis before delivery. Source references let your team inspect the evidence behind the findings.

Can we see an example first?

Yes. We can walk your team through a redacted sample of a competitive landscape, a target product profile, conference intelligence, and real-world evidence analysis. Ask for a walkthrough.

Can you keep the analysis current?

Yes. We agree what to refresh and on what cadence, based on your decision and how the evidence changes. The scope includes the evidence to revisit, the outputs to update, and the scientific review required.

How do you handle confidential questions and materials?

Confidentiality is covered by the terms we agree with your team. Contact us before sending sensitive materials. Our Trust page describes how we handle data and report security issues.

News

Research and company news

View all news

Your next decision starts here

What decision is
your team facing?

Bring us your question. We reply within one business day and help define the analysis that moves you forward.

Talk to our team